ZA855830B - Octahydro-oxazola(4,5-g)quinolines - Google Patents
Octahydro-oxazola(4,5-g)quinolinesInfo
- Publication number
- ZA855830B ZA855830B ZA855830A ZA855830A ZA855830B ZA 855830 B ZA855830 B ZA 855830B ZA 855830 A ZA855830 A ZA 855830A ZA 855830 A ZA855830 A ZA 855830A ZA 855830 B ZA855830 B ZA 855830B
- Authority
- ZA
- South Africa
- Prior art keywords
- oxazola
- quinolines
- octahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63723284A | 1984-08-02 | 1984-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA855830B true ZA855830B (en) | 1987-03-25 |
Family
ID=24555086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA855830A ZA855830B (en) | 1984-08-02 | 1985-08-01 | Octahydro-oxazola(4,5-g)quinolines |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0172697B1 (fr) |
| JP (1) | JPH0670063B2 (fr) |
| KR (1) | KR880001430B1 (fr) |
| AR (1) | AR240822A1 (fr) |
| AT (1) | ATE67766T1 (fr) |
| AU (1) | AU569406B2 (fr) |
| CA (1) | CA1292742C (fr) |
| DE (1) | DE3584205D1 (fr) |
| DK (1) | DK349185A (fr) |
| ES (2) | ES8704499A1 (fr) |
| GR (1) | GR851895B (fr) |
| HU (1) | HU193338B (fr) |
| IE (1) | IE58695B1 (fr) |
| IL (1) | IL75991A0 (fr) |
| NZ (1) | NZ212946A (fr) |
| PH (1) | PH22541A (fr) |
| PT (1) | PT80899B (fr) |
| SU (1) | SU1421258A3 (fr) |
| ZA (1) | ZA855830B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826986A (en) * | 1986-06-16 | 1989-05-02 | Eli Lilly And Company | 6-Oxo-trans-octa- and decahydroquinolines |
| US4762843A (en) * | 1986-09-15 | 1988-08-09 | Warner-Lambert Company | Hetero [f] fused carbocyclic pyridines as dopaminergic agents |
| US4939259A (en) * | 1989-07-24 | 1990-07-03 | Eli Lilly And Company | 2-oxo-pyrido[2,3-g]quinoline derivatives |
| US6395744B1 (en) | 1994-04-22 | 2002-05-28 | Queen's University At Kingston | Method and compositions for the treatment or amelioration of female sexual dysfunction |
| EP1089736A2 (fr) * | 1998-06-22 | 2001-04-11 | Queen's University At Kingston | Procede et compositions pour le traitement ou l'amelioration des dysfonctionnements sexuels de la femme |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4198415A (en) * | 1979-01-22 | 1980-04-15 | Eli Lilly And Company | Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines |
| IL75992A0 (en) * | 1984-08-03 | 1985-12-31 | Lilly Co Eli | Improvements in or relating to tricyclic quinoline derivatives |
| US4826986A (en) * | 1986-06-16 | 1989-05-02 | Eli Lilly And Company | 6-Oxo-trans-octa- and decahydroquinolines |
-
1985
- 1985-08-01 SU SU853932559A patent/SU1421258A3/ru active
- 1985-08-01 IL IL75991A patent/IL75991A0/xx not_active IP Right Cessation
- 1985-08-01 IE IE192185A patent/IE58695B1/en not_active IP Right Cessation
- 1985-08-01 KR KR1019850005554A patent/KR880001430B1/ko not_active IP Right Cessation
- 1985-08-01 DK DK349185A patent/DK349185A/da not_active Application Discontinuation
- 1985-08-01 CA CA000487985A patent/CA1292742C/fr not_active Expired - Lifetime
- 1985-08-01 PT PT80899A patent/PT80899B/pt not_active IP Right Cessation
- 1985-08-01 GR GR851895A patent/GR851895B/el unknown
- 1985-08-01 JP JP60170980A patent/JPH0670063B2/ja not_active Expired - Lifetime
- 1985-08-01 NZ NZ212946A patent/NZ212946A/xx unknown
- 1985-08-01 HU HU852964A patent/HU193338B/hu not_active IP Right Cessation
- 1985-08-01 PH PH32596A patent/PH22541A/en unknown
- 1985-08-01 ZA ZA855830A patent/ZA855830B/xx unknown
- 1985-08-02 AT AT85305538T patent/ATE67766T1/de not_active IP Right Cessation
- 1985-08-02 DE DE8585305538T patent/DE3584205D1/de not_active Expired - Lifetime
- 1985-08-02 ES ES545859A patent/ES8704499A1/es not_active Expired
- 1985-08-02 AU AU45737/85A patent/AU569406B2/en not_active Ceased
- 1985-08-02 EP EP85305538A patent/EP0172697B1/fr not_active Expired - Lifetime
-
1986
- 1986-02-13 ES ES551964A patent/ES8800231A1/es not_active Expired
- 1986-08-01 AR AR301157A patent/AR240822A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0172697A3 (en) | 1986-03-12 |
| GR851895B (fr) | 1985-12-03 |
| PH22541A (en) | 1988-10-17 |
| DK349185D0 (da) | 1985-08-01 |
| JPH0670063B2 (ja) | 1994-09-07 |
| KR880001430B1 (ko) | 1988-08-08 |
| HUT38348A (en) | 1986-05-28 |
| AR240822A2 (es) | 1991-02-28 |
| PT80899B (pt) | 1987-12-30 |
| IE851921L (en) | 1986-02-02 |
| ES8800231A1 (es) | 1987-10-16 |
| DE3584205D1 (de) | 1991-10-31 |
| CA1292742C (fr) | 1991-12-03 |
| EP0172697B1 (fr) | 1991-09-25 |
| IE58695B1 (en) | 1993-11-03 |
| IL75991A0 (en) | 1985-12-31 |
| EP0172697A2 (fr) | 1986-02-26 |
| AR240822A1 (es) | 1991-02-28 |
| HU193338B (en) | 1987-09-28 |
| JPS6147487A (ja) | 1986-03-07 |
| AU4573785A (en) | 1986-02-06 |
| PT80899A (en) | 1985-09-01 |
| KR860001815A (ko) | 1986-03-22 |
| SU1421258A3 (ru) | 1988-08-30 |
| ATE67766T1 (de) | 1991-10-15 |
| NZ212946A (en) | 1988-07-28 |
| AU569406B2 (en) | 1988-01-28 |
| ES545859A0 (es) | 1987-04-01 |
| ES551964A0 (es) | 1987-10-16 |
| ES8704499A1 (es) | 1987-04-01 |
| DK349185A (da) | 1986-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS78585A2 (en) | Zpusob vyroby 1,3 disubstituovanych 2 oxindolu | |
| GB2146993B (en) | Octahydropyrimido4,5-g quinolines | |
| PH19689A (en) | 1,3-dioxolo(4,5-g)quinolines | |
| ZA85575B (en) | 1,3,2-dioxaborinanes | |
| ZA855830B (en) | Octahydro-oxazola(4,5-g)quinolines | |
| GB2162175B (en) | 1,8-diacyloxy-10-acylanthrones | |
| ZA851236B (en) | 2-arylimidazo 4,5-cpyridines | |
| GB8421160D0 (en) | Pyrimido(4,5-g)quinolines | |
| GB2156353B (en) | 6,6-ethylenedioxy-22r-hydroxy-2r,3s-isopropylidenedioxy-5a-cholest-23-yne | |
| CS219684A1 (en) | Sposob pripravy 1 2,6 dimetylfenoxy 2 propylaminu | |
| IE851050L (en) | OCTAHYDROTHIAZOLO £4, 5-g| QUINOLINES | |
| EP0170822A3 (en) | 2,3-dihydrobenzo-4-oxa-thiine | |
| IE831831L (en) | 1,3-DIOXOLO (4,5-g) QUINOLINES | |
| IE840763L (en) | 6-H-DIBENZ (b,e) (1,4) OXATHIEPINS | |
| CS998884A1 (en) | Derivaty l,4 dihydropyridinu | |
| IE850681L (en) | 1,2, 4 - triazacycloalkadiene | |
| CS575184A1 (en) | Sposob vyroby 1,1 azobisformamidu | |
| CS804584A1 (en) | Zpusob pripravy oktafluor 1,3 cyklohexadienu | |
| IE841931L (en) | 3-Cl-1,2,4-TRIAZOL-1-YLPROP-1-ENES | |
| IE842024L (en) | 1,6-naphthyridines | |
| IE842726L (en) | 1, 2-dithiolanes | |
| CS815685A2 (en) | Zpusob vyroby 1,3 disubstituovanych 2 oxindolu | |
| CS664684A1 (en) | Zpusob pripravy 1,2 benzoxazolonu | |
| CS493984A1 (en) | Stabilizovany vodny injekcni roztok deamino1, karba1, 0 methyltyrosin2 oxytocinu | |
| CS449684A1 (en) | Zpusob rafinace 2,6 xylenolu |